FDA Townhall
Tuesday, June 04, 2024
Special Program
Regulatory Innovation
25ABC
Join us for a moderated discussion with the directors of the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, staffing, and key initiatives.
Speakers
Deputy Vice President, Science and Regulatory Affairs Strategy
Biotechnology Innovation Organization (BIO)
Speakers
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration
)